Dermatological features of inherited cancer syndromes in adults: Clinical dermatology

Clinical and Experimental Dermatology

Volumn 35, Issue 5, 2010, Pages 462-467

  Al Fares, A ^a   Millington, G W M ^b   Tischkowitz, M ^c,d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; BANNAYAN RILEY RUVALCABA SYNDROME; BIRT HOGG DUBE SYNDROME; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CONGENITAL DISORDER; COWDEN SYNDROME; DISEASE ASSOCIATION; GARDNER SYNDROME; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; INHERITANCE; KIDNEY CARCINOMA; LAUGIER HUNZIKER SYNDROME; LEIOMYOMATOSIS; MELANOMA; MUIR TORRE SYNDROME; NEOPLASM; PANCREAS CANCER; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; REVIEW; SCREENING; SKIN COLOR; SKIN DEFECT; SKIN PIGMENTATION;

ADULT; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; SKIN DISEASES;

EID: 77953333336     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03811.x     Document Type: Review

References (41)

1. Ponti G, de Ponz Leon M. Muir-Torre syndrome. Lancet Oncol 2005 6 : 980 987.
2. Ponti G, Losi L, Di Gregorio C et al. Identification of Muir-Torre syndrome among patients with sebaceous tumours and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005 103 : 1018 1025.
3. Ingram JR, Griffiths AP, Roberts DL. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome. Clin Exp Dermatol 2009 34 : 264 266.
4. Abbas O, Mahalingam M. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol 2009 36 : 613 619.
5. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006 101 : 385 398.
6. Giardiello FM, Offerhaus GJ, Krush AJ et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991 119 : 766 768.
7. Giardiello FM, Petersen GM, Brensinger JD et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 1996 39 : 867 869.
8. Millington GWM. Epigenetics and dermatological disease. Pharmacogenomics 2008 9 : 1835 1850.
9. Bishop JN, Harland M, Randerson-Moor J et al. Management of familial melanoma. Lancet Oncol 2007 8 : 46 54.
10. Millington GWM. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 2006 31 : 407 412.
11. MacCarthy A, Bayne AM, Draper GJ et al. Non-ocular tumours following retinoblastoma in Great Britain 1951-2004. Br J Ophthalmol 2009 93 : 1159 1162.
12. Marees T, Moll AC, Imhof SM et al. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 2008 100 : 1771 1779.
13. Giardiello FM, Welsh SB, Hamilton SR et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987 316 : 1511 1514.
14. Schreibman IR, Baker M, Amos C et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005 100 : 476 490.
15. Lampe AK, Hampton PJ, Woodford-Richens K et al. Laugier-Hunziker syndrome: an important differential diagnosis for Peutz-Jeghers syndrome. J Med Genet 2003 40 : e77.
16. Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns 2009 18 : 13 27.
17. Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 2008 27 : 5387 5397.
18. Marsh DJ, Kum JB, Lunetta KL et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 1999 8 : 1461 1472.
19. Lachlan KL, Lucassen AM, Bunyan D et al. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007 44 : 579 585.
20. Herman GE, Henninger N, Ratliff-Schaub K et al. Genetic testing in autism: how much is enough? Genet Med 2007 9 : 268 274.
21. Orrico A, Galli L, Buoni S et al. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet 2009 75 : 195 198.
22. Varga EA, Pastore M, Prior T et al. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 2009 11 : 111 117.
23. Toro JR, Glenn G, Duray P et al. Birt-Hogg-Dubé syndrome. a novel marker of kidney neoplasia. Arch Dermatol 1999 135 : 1195 1202.
24. Toro JR, Wei MH, Glenn GM et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008 45 : 321 331.
25. Sparling JD, Hong CH, Brahim JS et al. Oral findings in 58 adults with tuberous sclerosis complex. J Am Acad Dermatol 2007 56 : 786 790.
26. van Slegtenhorst M, Khabibullin D, Hartman TR et al. The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. J Biol Chem 2007 282 : 24583 24590.
27. Schaffer JV, Gohara MA, McNiff JM et al. Multiple facial angiofibromas. a cutaneous manifestation of Birt-Hogg-Dubé syndrome. J Am Acad Dermatol 2005 53 (Suppl. 1 S108 11.
28. Misago N, Narisawa Y. Fibrofolliculoma in a patient with tuberous sclerosis complex. Clin Exp Dermatol 2009 : DOI :.
29. Alam NA, Barclay E, Rowan AJ et al. Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumour syndrome. Arch Dermatol 2005 141 : 199 206.
30. Badeloe S, van Spaendonck-Zwarts KY, van Steensel MAM et al. Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol 2009 160 : 707 709.
31. Badeloe S, van Spaendonck-Zwarts KY, van Steensel MAM et al. Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol 2009 160 (3 707 709.
32. Hare HH, Mahendraker N, Sarwate S et al. Muir-Torre syndrome: a rare but important disorder. Cutis 2008 82 (4 252 256.
33. Wagner A, Barrows A, Wijnen JT et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003 72 (5 1088 1100.
34. Mitchell RJ, Farrington SM, Dunlop MG et al. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002 156 (10 885 902.
35. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001 121 (1 198 213.
36. Sieber OM, Lamlum H, Crabtree MD et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A 2002 99 (5 2954 2958.
37. Michils G, Tejpar S, Thoelen R et al. Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat 2005 25 (2 125 134.
38. Vasen HF, Gruis NA, Frants RR et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000 87 (6 809 811.
39. Aretz S, Stienen D, Uhlhaas S et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 2005 26 (6 513 519.
40. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 2006 4 (4 408 415.
41. Wei MH, Toure O, Glenn GM et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 2006 43 (1 18 27.